Chronic Myelomonocytic Leukemia Terminated Phase 3 Trials for Methotrexate (DB00563)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01749111Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD ProphylaxisPrevention